Comparison of B lineage markers confirmed that CD79a provides far superior sensitivity for interstitial B cells compared to CD19, establishing it as the requisite anchor for B cell burden assessment in FFPE lupus nephritis tissue. This evidence concerns the gene CD79A and lupus nephritis.